230 related articles for article (PubMed ID: 10605809)
1. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
Gulba DC
Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809
[No Abstract] [Full Text] [Related]
2. [Current use of anti-hemostatics in ischemic cardiopathy].
Bolao IG; Alegría E; Iglesias I; Velasco S; Fidalgo ML; Gómez JA; Huelmos A
Rev Med Univ Navarra; 1990; 34(4):219-26. PubMed ID: 2152748
[TBL] [Abstract][Full Text] [Related]
3. Acute coronary syndromes: new developments in pharmacological treatment strategies.
Gylys K; Gold M
Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169
[No Abstract] [Full Text] [Related]
4. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.
Puma JA; Sketch MH
J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119
[TBL] [Abstract][Full Text] [Related]
5. [Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence].
Páramo JA; García R; Rodríguez P; de Gaona ER
Rev Med Univ Navarra; 2007; 51(1):23-7. PubMed ID: 17555117
[TBL] [Abstract][Full Text] [Related]
6. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
[TBL] [Abstract][Full Text] [Related]
8. [Acute coronary syndromes with ST-segment elevation: fibrinolytic therapy].
Cuccia C
Ital Heart J; 2003 Dec; 4 Suppl 8():9S-15S. PubMed ID: 15005523
[No Abstract] [Full Text] [Related]
9. Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction.
Lincoff AM
J Invasive Cardiol; 2002 Feb; 14 Suppl A():1A-2A. PubMed ID: 11847401
[No Abstract] [Full Text] [Related]
10. [Acute coronary syndromes with ST-segment elevation: primary angioplasty].
Paoli G; Ardissino D
Ital Heart J; 2003 Dec; 4 Suppl 8():16S-20S. PubMed ID: 15005524
[No Abstract] [Full Text] [Related]
11. [Acute coronary syndromes without ST-elevation -- treatment].
Weber M; Hamm C
Dtsch Med Wochenschr; 2003 Feb; 128(6):273-6. PubMed ID: 12571797
[No Abstract] [Full Text] [Related]
12. [Mexican Cardiology Society Guidelines on the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Cancún, Quintana Roo 15-16 November 2002. Cooperative Group of Consensus].
Lupi-Herrera E;
Arch Cardiol Mex; 2002; 72 Suppl 2():S5-44. PubMed ID: 12661524
[TBL] [Abstract][Full Text] [Related]
13. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
14. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic agents in coronary artery disease.
Cairns JA; Hirsh J; Lewis HD; Resnekov L; Théroux P
Chest; 1992 Oct; 102(4 Suppl):456S-481S. PubMed ID: 1395829
[No Abstract] [Full Text] [Related]
16. [Prospective analysis of conservative treatment of acute coronary syndrome].
Niiazova-Karben ZA; Sidorenko BA; Batyraliev TA; Preobrazhenskiĭ DV; Pershukov IV; Pia IuV; Daniiarov BS
Kardiologiia; 2002; 42(5):34-7. PubMed ID: 12494146
[TBL] [Abstract][Full Text] [Related]
17. What role for catheter laboratories in unstable angina?
Topol EJ
Lancet; 1998 Aug; 352(9127):500-1. PubMed ID: 9716048
[No Abstract] [Full Text] [Related]
18. [Drug therapy of acute myocardial infarction and unstable coronary syndrome].
Gjesdal K; Aursnes I
Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2774-7. PubMed ID: 1977206
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombotics in pre-hospital phase of acute coronary syndromes].
Collet JP; Dumaine R; Ecollan P; Beygui F; Choussat R; Boon G; Payot L; Montalescot G
Arch Mal Coeur Vaiss; 2005 Nov; 98(11):1118-22. PubMed ID: 16379108
[TBL] [Abstract][Full Text] [Related]
20. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
